The current valuation score of Cyclerion Therapeutics Inc is 7.13, ranking 260 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.60, which is -512.94% below the recent high of 10.72 and -121.54% above the recent low of -5.75.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.